FDA Approval Activities for this Drug…

Crixivan (Indinavir Sulfate) Capsules, Merck & Co. NDA 20-685/S57 6/9/03 7/8/03 7/8/03 Crixivan (Indinavir Sulfate) Capsules, Merck & Co. NDA 20-685/S55 9/19/02 9/24/02 9/20/02 Crixivan (Indinavir Sulfate) Capsules, 100, 200, 333 & 400 mg Merck Research NDA 20-685/ S050, S053 & S056 6/20/02 6/24/02 6/21/02 Crixivan (Indinavir Sulfate) Capsules, 200 mg, 333 mg, and 400 mg Merck NDA 20-685/ S050 & S053 1/25/02 2/4/02 Crixivan (Indinavir Sulfate) Capsules, 200 mg, 333 mg, and 400 mg Merck NDA 20-685/ S041 3/21/01 4/25/01 4/25/03 Crixivan (Indinavir Sulfate) Merck NDA 020-685/ S022 Crixivan (Indinavir Sulfate) Capsules, Merck & Co. Inc. Crixivan (indinavir sulfate) capsules, Merck & Co., Inc. | Crixivan (indinavir sulfate) capsules, Merck & Co., Labeling Revision

For the latest approval information, please locate this drug using this index.